Lexicon Pharmaceuticals reported $694.92M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 209.42B 3.44B
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Acorda Therapeutics ACOR:US $ 51.17M 5.91M
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Akebia Therapeutics AKBA:US $ 502.67M 104.17M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Arena Pharmaceuticals ARNA:US $ 3.64B 526.29M
AstraZeneca AZN:LN 138.77B 24.78B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Clovis Oncology CLVS:US $ 528.11M 78.37M
Coherus Biosciences CHRS:US $ 1.23B 181.38M
Dicerna Pharmaceuticals DRNA:US $ 1.57B 1.3B
Eli Lilly And LLY:US $ 221.02B 902.49M
Esperion Therapeutics ESPR:US $ 340.74M 255.52M
Halozyme Therapeutics HALO:US $ 5.79B 675.56M
Illumina ILMN:US $ 63.48B 5.61B
Insmed INSM:US $ 3.26B 35.6M
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
Ironwood Pharmaceuticals IRWD:US $ 2.14B 52.76M
Johnson & Johnson JNJ:US $ 425145.86M 8679.8M
Lexicon Pharmaceuticals LXRX:US $ 694.92M 32.18M
Macrogenics MGNX:US $ 1.28B 335.6M
Mannkind MNKD:US $ 1.09B 274.39M
Merk MRK:US $ 190131.55M 6786.63M
Moderna Inc MRNA:US $ 155.35B 61B
Novartis NOVN:VX 187.04B 20.99B
Ptc Therapeutics PTCT:US $ 2.63B 355.33M
Puma Biotechnology PBYI:US $ 286.61M 83.91M
Regulus Therapeutics RGLS:US $ 60.11M 810.37K
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Thermo Fisher Scientific TMO:US $ 224.77B 26.5B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
United Therapeutics UTHR:US $ 8.29B 249.36M
Vanda Pharmaceuticals VNDA:US $ 953.64M 241.55M